Correlation Between Edgewise Therapeutics and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Cyteir Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Cyteir Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Cyteir Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Edgewise and Cyteir is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Cyteir Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.46 times less return on investment than Cyteir Therapeutics. In addition to that, Edgewise Therapeutics is 1.05 times more volatile than Cyteir Therapeutics. It trades about 0.07 of its total potential returns per unit of risk. Cyteir Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 136.00 in Cyteir Therapeutics on August 24, 2024 and sell it today you would earn a total of 140.00 from holding Cyteir Therapeutics or generate 102.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.85% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Cyteir Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Edgewise Therapeutics and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Cyteir Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
| Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |